Intravascular administration sets are accurate and in appropriate condition after 7 days of continuous use: An in vitro study

Journal of Advanced Nursing

Volumn 37, Issue 4, 2002, Pages 330-337

  Rickard, Claire M ^a   Wallis, Steven C ^b,c   Courtney, Mary ^d   Lipman, Jeff ^b,c   Daley, Peter J P ^b  

^a MONASH UNIVERSITY   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Infusion pumps; Infusions; Intravascular; Parenteral; Randomized controlled trial; Research

Indexed keywords

ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EQUIPMENT DESIGN; HUMAN; INFUSION PUMP; INSTRUMENTATION; INTRAVENOUS DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; STANDARD; SYRINGE; TIME;

ANALYSIS OF VARIANCE; EQUIPMENT DESIGN; HUMANS; INFUSION PUMPS; INFUSIONS, INTRAVENOUS; SYRINGES; TIME FACTORS;

EID: 0036482943     PISSN: 03092402     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2648.2002.02099.x     Document Type: Article

References (19)

1. ALARIS™ Medical Systems (1999) Product Information. Latex-free Infusion and Syringe Administration Sets (Reference Numbers 2210-0500 and 2280-0000). San Diego, CA, USA.
2. Band J.D. & Maki D.G. (1979) Safety of changing intravenous delivery systems at longer than 24-hour intervals. Annals of Internal Medicine 91, 173-178.
3. Buxton A.E., Highsmith A.K., Garner J.S., West C.M., Stamm W.E., Dixon R.E. & McGowan J.E. Jr (1979) Contamination of intravascular infusion fluid: effects of changing administration sets. Annals of Internal Medicine 90, 764-768.
4. Centers for Disease Control Working Group (1982) Guidelines for prevention of intravenous therapy-related infections. Infection Control 3, 62-79.
5. Chen Y.Y., Lin M., Lin M.Y., Wang F.D., Liu J.H. & Chang M.S. (2000) The central venous tubing change associated with catheter-related infection (Abstract). Infection Control and Hospital Epidemiology 21, 94.
6. Darouiche R.O. & Raad I. (1998) Prevention of infections associated with vascular catheters. In Yearbook of Intensive Care and Emergency Medicine 1998 (Vincent J.-L. ed.). Springer-Verlag Berlin, pp. 327-338.
7. Gorbea H.E., Snydman D.R., Delaney A., Stockman J. & Martin W.J. (1984) Intravenous tubing with burettes can be safely changed at 48-hour intervals. Journal of the American Medical Association 251, 2112-2115.
8. Jakobsen C.J., Grabe N., Nielsen E., Hojbjerg T., Damm M., Lorentzen K., Ersgaard H.V., Villadsen J., Heebol Holm B., Madsen J.I., Jespersen B., Lenler-Petersen P., Sorensen C.A., Jorgensen A.F. & Hvid H. (1986) Contamination of intravascular infusion systems - the effect of changing administration sets. Journal of Hospital Infection 8, 217-223.
9. Josephson A., Gombert M.E., Sierra M.F., Karanfil L.V. & Tansino G.F. (1985) The relationship between intravenous fluid contamination and the frequency of tubing replacement. Infection Control 6, 367-370.
10. Maki D.G. (1994) Infections caused by intravascular devices used for infusions therapy: pathogenesis, prevention and management. In Infections Associated with Indwelling Medical Devices (Bisno A.L. & Waldvogel F.A. eds), ASM Press, Washington, DC, pp. 155-205.
11. Maki D.G.D.G., Rhame F.S., Mackel D.C. & Bennett J.V. (1976) Nationwide epidemic of septicaemia caused by contaminated intravenous products: 1. Epidemiologic and clinical features. American Journal of Mediane 60, 471-485.
12. Maki D.G., Botticelli J.T., LeRoy M.L. & Thielke T.S. (1987) Prospective study of replacing administration sets for intravascular therapy at 48-vs. 72-hour intervals. 72 hours is safe and cost-effective. Journal of the American Medical Association 258, 1777-1781.
13. Matlow A.G., Kitai I., Kirpalani H., Chapman N.H., Corey M., Perlman M., Pencharz P., Jewell S., Phillips-Gordon C., Summerbell R. & Ford-Jones E.L. (1999) A randomised controlled trial of 72-versus 24-hour intravenous tubing administration set changes in newborns receiving lipid therapy. Infection Control and Hospital Epidemiology 20, 487-493.
14. Pearson M.L. (1996) Guideline for prevention of intravascular device-related infections. (CDC Guidelines). American Journal of Infection Control 24, 262-293.
15. Raad I., Darouiche R., Dupuis J., Abi Said D., Gabrielli A., Hachem R., Wall M., Harris R., Jones J., Buzaid A., Robertson C., Shenaq S., Curling P., Burke T. & Ericsson C. (1997) Central venous catheters coated with minocycline and rifampicin for the prevention of catheter-related colonization and bloodstream infections. A randomised, double-blind trial. The Texas Medical Center Catheter Study Group. Annals of Internal Medicine 127, 267-274.
16. Raad I., Hanna H.A., Awad A., Alrahwan A., Bivins C., Khan A., Richardson D., Umphrey J.L., Whimbey E. & Mansour G. (2001) Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours? Infection Control and Hospital Epidemiology 22, 136-139.
17. Robathan G., Woodger S. & Merante D. (1995) A prospective study evaluating the effects of extending total parenteral nutrition line changes to 72 hours. Journal of Intravascular Nursing 18, 84-87.
18. Sitges-Serra A., Linares J., Perez J.L., Jaurrieta E. & Lorente L. (1985) A randomised trial on the effect of tubing changes on hub contamination and catheter sepsis during parenteral nutrition. Journal of Parenteral and Enteral Nutrition 9, 322-325.
19. Snydman D.R., Donnely-Reidy M., Perry L.K. & Martin W.J. (1987) Intravenous tubing containing burettes can be safely changed at 72 hour intervals. Infection Control 8, 113-116.